Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
for the 1860-LIRA-DPP-4 Study Group
* **General Recommendation:** Due to the **lack of safety data**, the use of Tirzepatide (Zepbound) is **generally not recommended while breastfeeding.** Healthcare providers typically advise against using medications with unknown infant effects during lactation unless there is a compelling medical need for the mother that outweighs the potential, unknown risks to the baby
doi: 10.1016/S0021-9258(19)36565-2 8 LauJBlochPSchafferLPetterssonISpetzlerJKofoedJet al
Medicare, whether original or Medicare Advantage, covers semaglutide for type 2 diabetes or heart disease indication but not for weight loss
Secure checkout Credit and debit card checkout keeps the buying experience familiar from catalog to confirmation
